Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function.
Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function.
复制标题
DOI:
10.3389/fimmu.2013.00155
复制
发表时间:
2013
影响因子:
7.3
通讯作者:
Piaggio E
中科院分区:
文献类型:
--
作者:
Goldstein JD;Pérol L;Zaragoza B;Baeyens A;Marodon G;Piaggio E
CD4+CD25+Foxp3+ regulatory T cells (Tregs) are essential players in the control of immune responses. Recently, accordingly to their origin, two main subsets of Tregs have been described: thymus-derived Tregs (tTregs) and peripherally derived Tregs (pTregs). Numerous signaling pathways including the IL-2/STAT5 or the TGF-β/Smad3 pathways play a crucial role in segregating the two lineages. Here, we review some of the information existing on the distinct requirements of IL-2, TGF-β, and TNF-α three major cytokines involved in tTreg and pTreg generation, homeostasis and function. Today it is clear that signaling via the IL-2Rβ chain (CD122) common to IL-2 and IL-15 is required for proper differentiation of tTregs and for tTreg and pTreg survival in the periphery. This notion has led to the development of promising therapeutic strategies based on low-dose IL-2 administration to boost the patients’ own Treg compartment and dampen autoimmunity and inflammation. Also, solid evidence points to TGF-β as the master regulator of pTreg differentiation and homeostasis. However, therapeutic administration of TGF-β is difficult to implement due to toxicity and safety issues. Knowledge on the role of TNF-α on the biology of Tregs is fragmentary and inconsistent between mice and humans. Moreover, emerging results from the clinical use of TNF-α inhibitors indicate that part of their anti-inflammatory effect may be dependent on their action on Tregs. Given the profusion of clinical trials testing cytokine administration or blocking to modulate inflammatory diseases, a better knowledge of the effects of cytokines on tTregs and pTregs biology is necessary to improve the efficiency of these immunotherapies.
登录
查看更多内容
影响因子:
4.4
作者:
Burchill, Matthew A.;Yang, Jianying;Farrar, Michael A.
通讯作者:
Farrar, Michael A.
影响因子:
15.3
作者:
Fahlén, L;Read, S;Gorelik, L;Hurst, SD;Coffman, RL;Flavell, RA;Powrie, F
通讯作者:
Powrie, F
DOI:
10.1159/000289201
发表时间:
2010
期刊:
Current directions in autoimmunity
影响因子:
--
作者:
Chen X;Oppenheim JJ
通讯作者:
Oppenheim JJ
影响因子:
15.3
作者:
Ehrenstein, MR;Evans, JG;Singh, A;Moore, S;Warnes, G;Isenberg, DA;Mauri, C
通讯作者:
Mauri, C
影响因子:
4.4
作者:
Deepe, George S., Jr.;Gibbons, Reta S.
通讯作者:
Gibbons, Reta S.